SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as traders speculate on the timing of highly anticipated Phase 2 maintenance trial results for VK2735, with many investors anticipating significant upside or a potential acquisition if data proves superior to current obesity treatments. While some community members criticize the CEO's communication style and lack of updates at recent conferences, sentiment remains largely bullish with a focus on the underlying clinical data expected later this quarter.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending following a record fiscal fourth quarter characterized by significant revenue growth, a massive backlog, and robust forward guidance that signals strong demand for its electrical infrastructure equipment. Traders are responding positively to the company's manufacturing expansion and its ability to secure major contracts with hyperscale data centers, despite some prior debate regarding stock offerings.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is trending as investors weigh its upcoming regulatory and operational catalysts, including the Senate's CLARITY Act vote and the launch of the Arc mainnet. While some traders view these events as major growth drivers, others remain cautious, citing competition from banking-sector stablecoin initiatives and potential profit-taking after the stock's recent rally.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the reporting of positive final Phase 3 data for its kidney disease treatment, Trutakna, which showed significant reductions in disease progression and stabilized kidney function. While sentiment is largely bullish due to the potential for full FDA approval and best-in-class performance, some traders express frustration regarding recent price volatility and negative macro pressure on the biotech sector.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing significant community debate as traders weigh the potential for future defense contracts against frustration over delayed sales and persistent share dilution. While some investors remain optimistic about the company's role in the evolving drone warfare landscape, others express skepticism regarding executive leadership and the timing of meaningful revenue generation.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

The conversation surrounding DJT is dominated by intense political polarization and negative sentiment regarding the current administration's economic policies, including high energy costs, inflation, and the ongoing conflict in Iran. Traders are also actively discussing and debating recent news involving controversial financial and personal associations within the Trump family, while some market participants express skepticism about the company's long-term business viability.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as market participants debate its long-term growth potential and recent technical price action, with many noting frustration over persistent selling pressure despite new satellite delivery announcements and contract speculation. The conversation is largely characterized by a divide between bullish investors focusing on the company's backlog and space industry infrastructure role, and bearish traders who cite concerns over dilution, poor technical performance, and negative correlations with broader space sector volatility.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending due to heightened supply fears following reports that Saudi Arabia's key East-West pipeline was severely damaged by drone attacks, effectively cutting off a major crude transit artery. The community is sharply divided between bullish traders expecting further supply-driven price spikes toward record highs and bearish traders who view the move as an overextended rally susceptible to profit-taking or sudden diplomatic developments.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending following a significant share price decline, with the community debating whether the drop presents a buying opportunity or a warning sign regarding the company's valuation. While some traders are concerned about slowing consumer spending and premium P/E multiples, others maintain a bullish outlook based on the company's strong unit growth, debt-free expansion, and resilience relative to industry peers.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals shares are experiencing volatility and investor frustration as the community debates the impact of institutional price manipulation, algorithm-driven trading, and ongoing share price consolidation. Despite positive clinical pipeline developments, participants remain divided between those accumulating shares on dips and those expressing dismay over the lack of sustained momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates

Wave Life Sciences (WVE) delivered earnings and revenue surprises of -9.68% and -73.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Wave Life Sciences (WVE) Upgraded to Strong Buy: What Does It Mean for the Stock?

Wave Life Sciences (WVE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat?

Sarepta falls nearly 10% in a week after Dyne Therapeutics wins FDA priority review for a rival DMD therapy that could challenge Exondys 51 if approved.

New Strong Buy Stocks for July 22nd

HTLD, YEXT, ANIX, WVE and LCNB have been added to the Zacks Rank #1 (Strong Buy) List on July 22, 2026.

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid advances in personalized medicine and synthetic biology continue to transform the industry.

Is QURE Stock Attractive After Its Rally, Rich Valuation, and Hold?

QURE has soared on renewed AMT-130 optimism, but rich valuation, uneven earnings and pending regulatory milestones keep the gene therapy story balanced.

QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway

QURE's AMT-130 is driving investor focus as FDA feedback, a targeted third-quarter 2026 filing and cash into 2029 shape its regulatory outlook.

MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last?

MeiraGTx (MGTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Does Wave Life Sciences (WVE) Have the Potential to Rally 294.66% as Wall Street Analysts Expect?

The consensus price target hints at a 294.7% upside potential for Wave Life Sciences (WVE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Wave Life Sciences, Inc. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It develops and commercializes a pipeline of RNA medicines across a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Cambridge, MA.

Wave Life Sciences Inc.

WVE Stock Edges Up After Positive Early Data For Rare Disease Drug  

Equity

Bearish Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Current Price	$4.52
Prev Close	$4.58
Open	$4.56
Dividend Yield	0.00%
50-Day Moving Average	$5.51
Beta	1.57
Avg. Volume	3.36M
PE Ratio	-4.22

52-Week High	$21.73
52-Week Low	$4.49
Market Capitalization	$902.48M
EPS (Annual)	-$1.21
Price to Book	1.95
Revenue Per Employee	$134,785.49

Feed

News

Sentiment

Earnings

Fundamentals

Info

WVE Fundamentals